IN8bio Stock Quote INAB - Stock Price, News, Charts, Message Board, Trades

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
IN8bio Inc (INAB) Quote

IN8bio Inc (INAB)

0.231

0.004

( 1.76% )

Updated: 10:29:08

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

0.231

Bid

0.2306

Ask

0.233

Volume

119,602

0.225101 Day's Range 0.241

0.217 52 Week Range 2.48

Market Cap

Previous Close

0.227

Open

0.236

Last Trade

Last Trade Time

10:27:31

Financial Volume

$ 28,192

VWAP

0.235718

Average Volume (3m)

305,946

Shares Outstanding

46,786,948

Dividend Yield

-

PE Ratio

-0.36

Earnings Per Share (EPS)

-0.64

Revenue

-

Net Profit

-30.01M

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.in8bio.com

Headquarters

Wilmington, Delaware, USA

Founded

-

IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was $0.23. Over the last year, IN8bio shares have traded in a share price range of $ 0.217 to $ 2.48.

IN8bio currently has 46,786,948 shares outstanding. The market capitalization of IN8bio is $10.62 million. IN8bio has a price to earnings ratio (PE ratio) of -0.36.

FeaturedZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

IN8bio Announces Pricing of $12.4 Million Private Placement

Cash position now expected to fund current operating plan into 2026 Financing provides cash runway to advance the ongoing expansion cohorts in the Phase 1 trial of INB-100 for patients with Acute...

Form 8-K - Current report

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.024	-9.41176470588	0.255	0.2659	0.217	583388	0.22776433	CS
4	-0.0789	-25.4598257502	0.3099	0.35	0.217	350920	0.26022938	CS
12	-0.629	-73.1395348837	0.86	0.8919	0.217	305946	0.39926408	CS
26	-0.839	-78.4112149533	1.07	1.74	0.217	336873	0.8336254	CS
52	-0.7038	-75.2888318357	0.9348	2.48	0.217	409346	1.16245344	CS
156	-6.269	-96.4461538462	6.5	9.4241	0.217	597000	2.33285286	CS
260	-9.769	-97.69	10	10.319	0.217	561105	2.38081685	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ZPTAZapata Computing Holdings Inc	$ 0.1781 (131.30%)	363.74M
DRUGBright Minds Biosciences Inc	$ 5.72 (129.72%)	39.22M
DBGIDigital Brands Group Inc	$ 0.2379 (48.87%)	65.6M
GRTSGritstone bio Inc	$ 0.0731 (35.37%)	215.82M
WAVEEco Wave Power Global AB	$ 11.79 (35.05%)	180.61k
SEELSeelos Therapeutics Inc	$ 1.27 (-48.16%)	499.29k
NTBLNotable Labs Ltd	$ 0.265 (-33.75%)	995.83k
AMLIAmerican Lithium Corporation	$ 0.85985 (-22.54%)	1.74M
YYAIConnexa Sports Technologies Inc	$ 4.77 (-20.37%)	86.04k
LGHLWLion Group Holding Ltd	$ 0.0065 (-19.75%)	53.51k
ZPTAZapata Computing Holdings Inc	$ 0.1782 (131.43%)	363.74M
GRTSGritstone bio Inc	$ 0.0729 (35.00%)	215.87M
NVDANVIDIA Corporation	$ 133.3321 (-3.43%)	89.66M
DBGIDigital Brands Group Inc	$ 0.2372 (48.44%)	65.6M
DRUGBright Minds Biosciences Inc	$ 5.8511 (134.98%)	39.27M

Awl416

Awl416 2 weeks ago

IN8bio Announces Pricing of $12.4 Million Private Placement

BurgerKing82

BurgerKing82 1 month ago

glenn1919

glenn1919 1 month ago

INAB...........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783

TheFinalCD

TheFinalCD 1 month ago

$INAB 49% workforce reduction, focusing on INB-100https://t.co/C30I7yWH1v— Michelle Solly (@MSollender) September 4, 2024

Monksdream

Monksdream 2 months ago

INAB new 52 week low

glenn1919

glenn1919 4 months ago

INAB....................................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 4 months ago

INAB.................................https://stockcharts.com/h-sc/ui?s=INAB
&p=W&b=5&g=0&id=p86431144783

Tyrus603

Tyrus603 6 months ago

Talk about a delayed effect. But once more investors fully absorb the news... How big is the leukemia prescribed drug treatment market? Sky high run still possible.

Laster

Laster 6 months ago

Sold my shares this morning that I bought last night for small loss.
Volume not great. No PM movement (yet).
Who knows. It may surprise and take off at 9:30 open.
If it does, then congrats to y’all.

Invest-in-America

Invest-in-America 6 months ago

INAB: Their Post-M news relates only PRE-Human findings, etc., at this point --- but, you simply publish a MAYBE-WE-GOT-A-POTENTIAL-CANCER-CURE type of PR and well, you know, a PRICE Moon landing tomorrow morning maybe??? (Holding circa 35% up in the Post-M, at this writing.)

BOTTOM LINE??? GO-GO-GO-INAB!!!!

glenn1919

glenn1919 7 months ago

INAB.........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 8 months ago

murocman

murocman 10 months ago

Surprised how much this has tanked in light of stellar data?

Murocman

murocman

murocman 10 months ago

Outstanding data and financing in place to boot!

Should move up!

Murocman

Awl416

Awl416 10 months ago

IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia

Monksdream

Monksdream 1 year ago

Monksdream

Monksdream 1 year ago

INAB new 52 week low

Monksdream

Monksdream 1 year ago

INAB new 52 week low

The Night Stalker

The Night Stalker 1 year ago

https://stockcharts.com/h-sc/ui?s=inab&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

Mr Wick

Mr Wick 1 year ago

New INB 200 phase 1 data evaluating INB 200 patients will be available on Thursday 25 May. Also being presented at ASCO annual meeting on 02 June.
Fingers crossed.

The Night Stalker

The Night Stalker 1 year ago

MrMocha

MrMocha 1 year ago

I agree, INAB is going to do great things. A majority of their trials so far show great promise! I’m excited to see what their future holds..I can definitely see them being acquired in the not so distant future. Great find Mr Wick!

Mr Wick

Mr Wick 1 year ago

New to ihub. Found in8bio a few weeks ago after the huge run recently. After researching I told a friend that " in8bio might be the best sleeper stock I have ever seen".
Looking forward to a buyout.

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

Trons

Trons 1 year ago

Headed to $20 on cancer developments

Jess070283

Jess070283 1 year ago

Uh oh Shorts I’m trouble….

trendzone

trendzone 1 year ago

Real DUMBASS move by the company this mornings news of offerings, but with the other big news out this week, it's probably a screaming buy on the reversal selloff, and sellers are acting like the fools that they are.

Jess070283

Jess070283 1 year ago

Loading this dip for the rip…

Invest-in-America

Invest-in-America 1 year ago

INAB: It is CUTE!! (Hey, Boss, PBLA & INAB lookin' interesting; so too SAI, of course.)

TheFinalCD

TheFinalCD 1 year ago

Update: IN8bio's INB-400, INB-410 Secure US FDA's Orphan Drug Designation -- Shares Surge Premarket
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target

subslover

subslover 1 year ago

Love your scanner! :)

2020Benzo

2020Benzo 1 year ago

Did they just post same Orphan Drug news twice in a row it’s sane PR !

TheFinalCD

TheFinalCD 1 year ago

surf1944

surf1944 1 year ago

https://stockcharts.com/h-sc/ui?s=inab&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/inab/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/inab/opinion

Back down to $1

ringo1

ringo1 1 year ago

Time to take some profits

Hercules1

Hercules1 1 year ago

It hit $3.95.

$4 break is coming.

$5 quite possible today.

Hercules1

Hercules1 1 year ago

Total beast.

Next stop $4.

And then $5.

Awl416

Awl416 1 year ago

Jess070283

Jess070283 1 year ago

Invest-in-America

Invest-in-America 1 year ago

INAB: Maybe I've gone BONKERS, but this little freak show could hit TEN-BUCKS-A-SHARE today, Peeps!!!! (At least that's what my 'SCANNER' just told me!! See below!!)

Delayed Upgrade Clock